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Abstract:Metastatic disease to the breast from extra mammary sites
is uncommon and has an incidence of 0.5 to 3%. It is important to
make an accurate diagnosis as this has an impact on the therapeutic
planning and management. Clinically, it can be difficult to differ-
entiate between primary breast cancer and a metastatic disease. An
incorrect diagnosis can lead to unnecessary surgical interventions.
Immunohistochemistry has a significant role in identifying the
primary origin of tumor and has to be considered in the presence of
unusual cytologic patterns. We report three cases of metastatic
disease to breast from primary lung tumors. The cases demonstrate
the difficulties encountered in the diagnosis and the impact on the
management of these patients.
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Breast is an unusual site for metastases particularly fromprimary lung cancer. Metastases to the breast from non-
mammary malignant neoplasms are rare and an autopsy series
showed that metastases accounted for 0.5 to 6.6% of all breast
malignancies.1,2 Metastatic spread to the breast has an inci-
dence of 0.5 to 3% from extramammary sites.3,4 We report
three unusual cases of metastases to the breast from primary
lung cancer.
Case I
A 51-year-old smoker with a 30 pack year history was
referred to the breast surgeons for an enlarging lump in the
axillary tail of her left breast. The lump exhibited skin
tethering and was suspicious of primary breast malignancy.
Mammography demonstrated a radiologically malignant ill-
defined rounded mass lesion in the left upper outer quadrant,
fine-needle aspiration of which revealed malignant cells. A
chest radiograph was normal. She underwent ultrasound
guided core biopsy of the left breast. Histopathological ex-
amination of this core demonstrated an infiltrating carcinoma
consistent with an origin in breast which was confirmed by a
trucut biopsy (Figure 1). She therefore underwent wide local
excision and axillary node clearance. Histopathological ex-
amination of this specimen showed grade 3, node negative
carcinoma of no special type. The tumor was estrogen recep-
tor (ER), progesterone receptor (PR) and Herceptin negative.
A month after excision of the breast mass the patient
developed subcutaneous lumps in her abdominal wall and
right thigh. Mediastinal adenopathy was evident on the com-
puted tomography (CT) scan of the thorax, abdomen, and
pelvis (Figure 2). There were multiple small opacities in both
lungs measuring up to 6 mm suggestive of pulmonary me-
tastases. There was also a 6 mm subcutaneous deposit in the
medial aspect of her right breast that was consistent with a
skin deposit with a further 9 mm lesion noted in the abdom-
inal wall, and a 13 mm right posterior thigh nodule. The
radiologic picture was felt to be less likely to represent
metastatic breast cancer. She therefore underwent trucut bi-
opsy of the nodules from the abdominal wall and thigh.
Histopathological examination of both biopsies showed inva-
sive adenocarcinoma which with immunohistochemical stain-
ing, were strongly positive for CK7 and TTF1 but negative
for ER and PR. In retrospect, immunohistochemistry of the
resected breast tissue also confirmed widespread nuclear
positivity of the specimen to TTF1 (Figure 3). This lady was
treated with platinum based chemotherapy for stage IV non-
small cell lung cancer and is currently under follow-up at the
time of writing this report.
Case II
A 69-year-old woman was admitted with breathless-
ness, chest pain, and a breast lump. She was a smoker and had
a background of atrial fibrillation, chronic obstructive pulmo-
nary disease, and hypertension. Clinical examination revealed
a 4  2 cm hard mass in the right breast. A right sided
rounded opacity was seen on her chest radiograph. She
underwent a CT of chest and abdomen which demonstrated
two nodules in the right lung, the largest of which measured
2 cm in diameter with a right breast mass (Figure 4). There
was a mediastinal mass encasing both main stem bronchi and
a right axillary node. Below the diaphragm there were ring
enhancing lesions in both lobes of the liver, and a soft tissue
lesion in the right arm consistent with metastases.
She underwent core biopsy of the breast mass and
histopathological examination showed a small cell carcinoma
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confirmed by immunohistochemical staining showing strong
positive staining for TTF1 with dot type positivity for AE1/3
and strong membranous positivity for CD 56. In view of her
poor performance status she was deemed not fit for systemic
treatment and she died in the hospital.
Case III
An 82-year-old woman smoker with a background of
chronic obstructive pulmonary disease was admitted with
increasing breathlessness. Clinical examination revealed a
left sided 2  2 cm, hard and fixed breast lump, and signs of
a right sided effusion with no evidence of lymphadenopathy.
Chest radiograph demonstrated right middle and lower lobe
consolidation and fluid. CT scan of the chest confirmed the
clinical impression of a malignant left breast mass with
extensive mediastinal and right hilar lymphadenopathy, few
intrapulmonary nodules, right middle and lower lobe consol-
idation with right pleural effusion, and a small stellate opacity
in the left upper lobe. There were also widespread hepatic and
probable spleenic metastases. Histopathological examination
of a core biopsy of the breast mass showed an infiltrating
poorly differentiated carcinoma consistent with primary breast
origin. However, immunohistochemical staining showed the
tumor to be ER/PR, Hercept test negative and TTF1, CD56,
and P63 positive in keeping with a large cell neuroendocrine
FIGURE 1. Trucut biopsy of breast lump shows sheets of
pleomorphic cells with a moderate amount of cytoplasm
consistent with poorly differentiated carcinoma (hematoxy-
lin-eosin, 200).
FIGURE 2. Computed tomography (CT) scan of the thorax,
abdomen, and pelvis showed evidence of extensive mediasti-
nal lymphadenopathy, predominantly in the right hilar, pre-
carinal, and pretracheal regions.
FIGURE 3. Immunohistochemical staining of resected
breast tissue shows widespread nuclear positivity for TTF-1
(TTF-1, 200).
FIGURE 4. Computed tomography (CT) of chest showing
the right breast mass (arrow) and extensive mediastinal
adenopathy.
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carcinoma of lung. This patient underwent palliative radio-
therapy but died a few weeks later.
DISCUSSION
Metastatic cancer is an unexpected diagnosis in a
female patient presenting with a breast mass and is rela-
tively uncommon due to large area of fibrous tissue and
relatively poor blood supply of the breast.5 The commonest
cause is spread from a contralateral primary breast carci-
noma.6 The most common primary tumors metastasizing to
the breast include melanoma and lymphoma.7 Lung, ovar-
ian cancer, and soft tissue tumors uncommonly metastasize
to the breast.8 Although the typical presentation of primary
breast cancers include pain, tenderness and nipple dis-
charge, metastases to the breast from extramammary sites
usually present as solitary breast masses.
In most situations, metastatic disease to the breast
occurs after the diagnosis of the primary tumor. In approxi-
mately 25% of patients, a breast mass is the cause for the
initial presentation. In these patients, metastases to the breast
can mimic benign disease or primary breast malignancies.9 In
all of these three cases, a breast mass was the initial mode of
presentation.
Most metastatic breast masses present as palpable
painless lumps and skin tethering is uncommon. One of
our patients (case I) had skin tethering making the diag-
nosis of metastasis in the breast extremely unlikely. Dif-
fuse skin involvement, however, has been reported with
melanoma metastasizing to the breast.10 Clinically, it can
be difficult to differentiate between primary cancers that
metastasize to the breast and primary breast carcinomas.
Metastases to the breast typically lie in the subcutaneous
plane and hence are usually palpable. Primary breast carcinomas
arise from the glandular epithelium and are usually deep seated
but also often palpable.11 In all our cases the breast lump was
palpable.
Mammography usually reveals a well defined rounded
mass and multiple or bilateral lesions are seen in a minority
of cases.11 In contrast with primary breast cancers, calcifica-
tion is rare and speculation uncommon.12
Breast masses presenting as metastatic spread from pri-
mary lung cancer can be difficult to diagnose in the absence of
new and concerning respiratory symptoms (e.g., cough, hemop-
tysis). Histopathology can provide the diagnosis. However in
most instances immunohistochemical staining is required to
confirm the primary site of the tumor as evidenced in case I.
The outcome for this group of patients is poor and 80% of
patients with breast metastases arising from lung die within 1
year of presentation.13 In our series, two patients had died by
the time of reporting and case I had received chemotherapy.
Metastatic masses in the breast are uncommon with the
commonest reported source being from a melanoma primary.
Lung cancer presenting as a metastasis in the breast is
uncommon. It is important to consider this possibility, par-
ticularly in smokers, to avoid an incorrect diagnosis and
unnecessary surgery and in this regard, immunohistochemis-
try is essential.
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